Impact of tricuspid regurgitation on survival in patients with chronic heart failure: Unexpected findings of a long-term observational study

European Heart Journal

Volumn 34, Issue 11, 2013, Pages 844-852

  Neuhold, Stephanie ^a,b   Huelsmann, Martin ^a   Pernicka, Elisabeth ^a   Graf, Alexandra ^a   Bonderman, Diana ^a   Adlbrecht, Christopher ^a   Binder, Thomas ^a   Maurer, Gerald ^a   Pacher, Richard ^a   Mascherbauer, Julia ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of Anaesthesia   (Austria)

Author keywords

Chronic heart failure; Outcome; Tricuspid regurgitation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; SODIUM;

ADULT; AGED; ARTICLE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SURVIVAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; TRICUSPID VALVE REGURGITATION; VENTRICULAR ASSIST DEVICE;

CHRONIC DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, SYSTOLIC; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; TRICUSPID VALVE INSUFFICIENCY;

EID: 84875187696     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs465     Document Type: Article

References (29)

1. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002;144:524-529.
2. Hung J, Koelling T, Semigran MJ, Dec GW, Levine RA, Di Salvo TG. Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy. Am J Cardiol 1998;82:1301-1303, A10.
3. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43:405-409.
4. Topilsky Y, Khanna AD, Oh JK, Nishimura RA, Enriquez-Sarano M, Jeon YB, Sundt TM, Schaff HV, Park SJ. Preoperative factors associated with adverse outcome after tricuspid valve replacement/clinical perspective. Circulation 2011; 123:1929-1939.
5. Mascherbauer J, Maurer G. The forgotten valve: lessons to be learned in tricuspid regurgitation. Eur Heart J 2010;31:2841-2843.
6. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008;10:933-989.
7. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 Focused update incorporated into the ACC/ AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-e90.
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
9. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, Hagendorff A, Monin JL, Badano L, Zamorano JL. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11:307-332.
10. Zamorano J-L, Bax J, Rademakers F, Knuuti J. The ESC Textbook of Cardiovascular Imaging. Springer 2010, 172-174.
11. Tribouilloy CM, Enriquez-Sarano M, Bailey KR, Tajik AJ, Seward JB. Quantification of tricuspid regurgitation by measuring the width of the vena contracta with color Doppler flow imaging: a clinical study. J Am Coll Cardiol 2000;36:472-478.
12. Topilsky Y, Tribouilloy C, Michelena HI, Pislaru S, Mahoney DW, Enriquez-Sarano M. Pathophysiology of tricuspid regurgitation: quantitative Doppler echocardiographic assessment of respiratory dependence. Circulation 2010;122:1505-1513.
13. Rivera JM, Vandervoort PM, Mele D, Siu S, Morris E, Weyman AE, Thomas JD. Quantification of tricuspid regurgitation by means of the proximal flow convergence method: a clinical study. Am Heart J 1994;127:1354-1362.
14. Taramasso M, Vanermen H, Maisano F, Guidotti A, La Canna G, Alfieri O. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol 2012;59:703-710.
15. Mascherbauer J, Fuchs C, Pernicka E, Wollenek G, Rosenhek R, Bonderman D, Maurer G, Baumgartner H. Predictors of outcome of non-ischemic mitral valve surgery. Int J Cardiol 2011; doi:10.1016/j.icard.2011.07.088. Published online ahead of print 19 August 2011.
16. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358:2148-2159.
17. Garner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-1743.
18. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R. B-Type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-2397.
19. Chen A, Wood MJ, Krauser D, Baggish AL, Tung R, Anwaruddin S, Picard MH, Januzzi JL. Nt-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoe in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J 2006; 27:839-845.
20. Richards AM, Nicholls G, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton C, Turner J, Crozier IG, Yandle TG. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003;107: 2786-2792.
21. Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Pina IL, Felker GM, Adams KF, Califf RM, Gheorghiade M. Investigators OPTIME-CHF. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure. Circulation 2005;111: 2454-2460.
22. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-210.
23. Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM, Hayes DL. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol 2005;45: 1672-1675.
24. Iskandar SB, Ann Jackson S, Fahrig S, Mechleb BK, Garcia ID. Tricuspid valve malfunction and ventricular pacemaker lead: case report and review of the literature. Echocardiography 2006;23:692-697.
25. Paniagua D, Aldrich HR, Lieberman EH, Lamas GA, Agatston AS. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol 1998;82:1130-1132.
26. Authors/Task Force Members, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baro n-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012; 33:2451-2496.
27. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;118: e523-e661.
28. McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM, Blackstone EH. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004;127:674-685.
29. Raja SG, Dreyfus GD. Surgery for functional tricuspid regurgitation: current techniques, outcomes and emerging concepts. Expert Rev Cardiovasc Ther 2009;7: 73-84.